Comparison of SARS-CoV-2 Antibody Responses and Seroconversion in COVID-19 Patients Using Twelve Commercial Immunoassays

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody assays have high clinical utility in managing the pandemic. We compared antibody responses and seroconversion of coronavirus disease 2019 (COVID-19) patients using different immunoassays. METHODS: We evaluated 12 comme...

Descripción completa

Detalles Bibliográficos
Autores principales: Yun, Sojeong, Ryu, Ji Hyeong, Jang, Joo Hee, Bae, Hyunjoo, Yoo, Seung-Hyo, Choi, Ae-Ran, Jo, Sung Jin, Lim, Jihyang, Lee, Jehoon, Ryu, Hyejin, Cho, Sung-Yeon, Lee, Dong-Gun, Lee, Jongmin, Kim, Seok Chan, Park, Yeon-Joon, Lee, Hyeyoung, Oh, Eun-Jee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Laboratory Medicine 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203431/
https://www.ncbi.nlm.nih.gov/pubmed/34108285
http://dx.doi.org/10.3343/alm.2021.41.6.577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203431/
https://www.ncbi.nlm.nih.gov/pubmed/34108285
http://dx.doi.org/10.3343/alm.2021.41.6.577

Ejemplares similares